Molecular Epidemiology and Mechanisms of Carbapenem Resistance of Acinetobacter spp. In Asia and Oceania

Microbial Drug Resistance

Volumn 21, Issue 4, 2015, Pages 424-434

  Kamolvit, Witchuda ^a,b   Sidjabat, Hanna E ^a   Paterson, David L ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CARBAPENEMASE; METALLO BETA LACTAMASE; OXACILLINASE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BETA LACTAMASE;

ACINETOBACTER; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC RESISTANCE; ARTICLE; ASIA; MICROBIAL POPULATION DYNAMICS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PACIFIC ISLANDS; PRIORITY JOURNAL; ACINETOBACTER BAUMANNII; DRUG EFFECTS; EPIDEMIOLOGY; GENETICS; HUMAN; MULTIDRUG RESISTANCE;

ACINETOBACTER; ACINETOBACTER BAUMANNII;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ASIA; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MOLECULAR EPIDEMIOLOGY; OCEANIA;

EID: 84937785521     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2014.0234     Document Type: Article

References (117)

1. Adams, M.D., E.R. Chan, N.D. Molyneaux, and R.A. Bonomo. (2010). Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 54: 3569-3577
2. Afzal-Shah, M., N. Woodford, and D.M. Livermore. (2001). Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 45: 583-588
3. Amudhan, M.S., U. Sekar, A. Kamalanathan, and S. Balaraman. (2012). blaIMP, and blaVIM mediated carbapenem resistance in Pseudomonas, and Acinetobacter species in India. J. Infect. Dev. Ctries. 6: 757-762
4. Apisarnthanarak, A., and L.M. Mundy. (2009). Mortality associated with Pandrug-resistant Acinetobacter baumannii infections in Thailand. Am. J. Infect. Control 37: 519-520
5. Bartual, S.G., H. Seifert, C. Hippler, M.A. Luzon, H. Wisplinghoff, and F. Rodriguez-Valera. (2005). Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43: 4382-4390
6. Bernards, A.T., J. van der Toorn, C.P. van Boven, and L. Dijkshoorn. (1996). Evaluation of the ability of a commercial system to identify Acinetobacter genomic species. Eur. J. Clin. Microbiol. Infect. Dis. 15: 303-308
7. Bosshard, P.P., R. Zbinden, S. Abels, B. Boddinghaus, M. Altwegg, and E.C. Bottger. (2006). 16S rRNA gene sequencing versus the API 20 NE system, and the VITEK 2 ID-GNB card for identification of nonfermenting Gramnegative bacteria in the clinical laboratory. J. Clin. Microbiol. 44: 1359-1366
8. Brown, S., and S.G. Amyes. (2005). The sequences of seven class D beta-lactamases isolated from carbapenemresistant Acinetobacter baumannii from four continents. Clin. Microbiol. Infect. 11: 326-329
9. Brown, S., H.K. Young, and S.G. Amyes. (2005). Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin. Microbiol. Infect. 11: 15-23
10. Bush, K., G.A. Jacoby, and A.A. Medeiros. (1995). A functional classification scheme for beta-lactamases, and its correlation with molecular structure. Antimicrob. Agents Chemother. 39: 1211-1233
11. Chang, H.C., Y.F. Wei, L. Dijkshoorn, M. Vaneechoutte, C.T. Tang, and T.C. Chang. (2005). Specieslevel identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J. Clin. Microbiol. 43: 1632-1639
12. Chen, Y., Z. Zhou, Y. Jiang, and Y. Yu. (2011). Emergence of NDM-1-producing Acinetobacter baumannii in China. J. Antimicrob. Chemother. 66: 1255-1259
13. Chen, Z., W. Liu, Y. Zhang, Y. Li, Z. Jian, H. Deng, M. Zou, and Y. Liu. (2013). Molecular epidemiology of carbapenem-resistant Acinetobacter spp. from XiangYa Hospital, in Hunan Province, China. J. Basic Microbiol. 53: 121-127
14. Chu, Y.W., M. Afzal-Shah, E.T. Houang, M.I. Palepou, D.J. Lyon, N. Woodford, and D.M. Livermore. (2001). IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994, and 1998. Antimicrob. Agents Chemother. 45: 710-714
15. Chuang, Y.C., W.H. Sheng, T.L. Lauderdale, S.Y. Li, J.T. Wang, Y.C. Chen, and S.C. Chang. (2013). Molecular epidemiology, antimicrobial susceptibility, and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan. J. Microbiol. Immunol. Infect. 47: 324-332
16. Chuang, Y.Y., Y.C. Huang, C.H. Lin, L.H. Su, and C.T. Wu. (2009). Epidemiological investigation after hospitalising a case with pandrug-resistant Acinetobacter baumannii infection. J. Hosp. Infect. 72: 30-35
17. Dai, W., S. Huang, S. Sun, J. Cao, and L. Zhang. (2013). Nosocomial spread of carbapenem-resistant Acinetobacter baumannii (types ST75, and ST137) carrying blaOXA-23-like gene with an upstream ISAba1 in a Chinese hospital. Infect. Genet. Evol. 14: 98-101
18. del Mar Tomas, M., A. Beceiro, A. Perez, D. Velasco, R. Moure, R. Villanueva, J. Martinez-Beltran, and G. Bou. (2005). Cloning, and functional analysis of the gene encoding the 33- to 36-kilodalton outer membrane protein associated with carbapenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49: 5172-5175
19. Di Popolo, A., M. Giannouli, M. Triassi, S. Brisse, and R. Zarrilli. (2011). Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme. Clin. Microbiol. Infect. 17: 197-201
20. Diancourt, L., V. Passet, A. Nemec, L. Dijkshoorn, and S. Brisse. (2010). The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5: e10034
21. Dijkshoorn, L., H. Aucken, P. Gerner-Smidt, P. Janssen, M.E. Kaufmann, J. Garaizar, J. Ursing, and T.L. Pitt. (1996). Comparison of outbreak, and nonoutbreak Acinetobacter baumannii strains by genotypic, and phenotypic methods. J. Clin. Microbiol. 34: 1519-1525
22. Dijkshoorn, L., A. Nemec, and H. Seifert. (2007). An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5: 939-951
23. Endo, S., H. Yano, Y. Hirakata, K. Arai, H. Kanamori, M. Ogawa, M. Shimojima, N. Ishibashi, T. Aoyagi, M. Hatta, et al. (2012). Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan. J. Antimicrob. Chemother. 67: 1623-1626
24. Evans, B.A., and S.G. Amyes. (2014). OXA beta-lactamases. Clin. Microbiol. Rev. 27: 241-263
25. Evans, B.A., A. Hamouda, K.J. Towner, and S.G. Amyes. (2008). OXA-51-like beta-lactamases, and their association with particular epidemic lineages of Acinetobacter baumannii. Clin. Microbiol. Infect. 14: 268-275
26. Gales, A.C., R.N. Jones, and H.S. Sader. (2006). Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin. Microbiol. Infect. 12: 315-321
27. Gales, A.C., R.N. Jones, and H.S. Sader. (2011). Contemporary activity of colistin, and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-2009). J. Antimicrob. Chemother. 66: 2070-2074
28. Hamidian, M., and R.M. Hall. (2011). AbaR4 replaces AbaR3 in a carbapenem-resistant Acinetobacter baumannii isolate belonging to global clone 1 from an Australian hospital. J. Antimicrob. Chemother. 66: 2484-2491
29. Hamouda, A., B.A. Evans, K.J. Towner, and S.G. Amyes. (2010). Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of blaOXA-51-like genes. J. Clin. Microbiol. 48: 2476-2483
30. Hamouda, A., J. Findlay, L. Al Hassan, and S.G. Amyes. (2011). Epidemiology of Acinetobacter baumannii of animal origin. Int. J. Antimicrob. Agents 38: 314-318
31. Hasan, B., K. Perveen, B. Olsen, and R. Zahra. (2014). Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan. J.Med.Microbiol. 63: 50-55
32. Higgins, P.G., C. Dammhayn, M. Hackel, and H. Seifert. (2010). Global spread of carbapenem-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 65: 233-238
33. Higgins, P.G., M. Lehmann, H. Wisplinghoff, and H. Seifert. (2010). gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus, and Acinetobacter genomic species 3. J. Clin. Microbiol. 48: 4592-4594
34. Higgins, P.G., F.J. Perez-Llarena, E. Zander, A. Fernandez, G. Bou, and H. Seifert. (2013). OXA-235, a novel class D beta-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 57: 2121-2126
35. Higgins, P.G., L. Poirel, M. Lehmann, P. Nordmann, and H. Seifert. (2009). OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 53: 5035-5038
36. Ho, C.M., M.W. Ho, C.Y. Chi, C.D. Lin, C.W. Lin, S.P. Tseng, L.J. Teng, H.Y. Chang, H.L. Chang, Y.F. Chang, et al. (2013). Repeated colonization by multi-drug-resistant Acinetobacter calcoaceticus-A. baumannii complex, and changes in antimicrobial susceptibilities in surgical intensive care units. Surg. Infect. 14: 43-48
37. Ho, P.L., A.Y. Ho, K.H. Chow, E.L. Lai, P. Ching, and W.H. Seto. (2010). Epidemiology, and clonality of multidrug-resistant Acinetobacter baumannii from a healthcare region in Hong Kong. J. Hosp. Infect. 74: 358-364
38. Hu, H., Y. Hu, Y. Pan, H. Liang, H. Wang, X. Wang, Q. Hao, X. Yang, X. Yang, X. Xiao, et al. (2012). Novel plasmid, and its variant harboring both a blaNDM-1 gene, and type IV secretion system in clinical isolates of Acinetobacter lwoffii. Antimicrob. Agents Chemother. 56: 1698-1702
39. Huang, L., L. Sun, and Y. Yan. (2013). Clonal spread of carbapenem resistant Acinetobacter baumannii ST92 in a Chinese Hospital during a 6-year period. J. Microbiol. (Seoul, Korea) 51: 113-117
40. Huang, L.Y., P.L. Lu, T.L. Chen, F.Y. Chang, C.P. Fung, and L.K. Siu. (2010). Molecular characterization of beta-lactamase genes, and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan. Antimicrob. Agents Chemother. 54: 2699-2703
41. Islam, M.A., P.K. Talukdar, A. Hoque, M. Huq, A. Nabi, D. Ahmed, K.A. Talukder, M.A. Pietroni, J.P. Hays, A. Cravioto, et al. (2012). Emergence of multidrug-resistant NDM-1-producing Gram-negative bacteria in Bangladesh. Eur. J. Clin. Microbiol. Infect. Dis. 31: 2593-2600
42. Jeong, H.W., H.J. Cheong, W.J. Kim, M.J. Kim, K.J. Song, J.W. Song, H.S. Kim, and K.H. Roh. (2009). Loss of the 29-kilodalton outer membrane protein in the presence of OXA-51-like enzymes in Acinetobacter baumannii is associated with decreased imipenem susceptibility. Microb. Drug Resist. 15: 151-158
43. Jones, R.N., L.M. Deshpande, J.M. Bell, J.D. Turnidge, S. Kohno, Y. Hirakata, Y. Ono, Y. Miyazawa, S. Kawakama, M. Inoue, et al. (2004). Evaluation of the contemporary occurrence rates of metallo-beta-lactamases in multidrug-resistant Gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998-2002). Diagn. Microbiol. Infect. Dis. 49: 289-294
44. Kaase, M., F. Szabados, N. Pfennigwerth, A. Anders, G. Geis, A.B. Pranada, S. Rossler, U. Lang, and S.G. Gatermann. (2014). Description of the metallo-beta-lactamase GIM-1 in Acinetobacter pittii. J. Antimicrob. Chemother. 69: 81-84
45. Kamolvit, W., P.G. Higgins, D.L. Paterson, and H. Seifert. (2013). Multiplex PCR to detect the genes encoding naturally occurring oxacillinases in Acinetobacter spp. J. Antimicrob. Chemother. 69: 959-963
46. Kansakar, P., D. Dorji, P. Chongtrakool, S. Mingmongkolchai, B. Mokmake, and P. Dubbs. (2011). Local dissemination of multidrug-resistant Acinetobacter baumannii clones in a Thai hospital. Microb. Drug Resist. 17: 109-119
47. Karthikeyan, K., M.A. Thirunarayan, and P. Krishnan. (2010). Coexistence of blaOXA-23 with blaNDM-1, and armA in clinical isolates of Acinetobacter baumannii from India. J. Antimicrob. Chemother. 65: 2253-2254
48. Karunasagar, A., B. Maiti, M. Shekar, M.S. Shenoy, and I. Karunasagar. (2011). Prevalence of OXA-Type carbapenemase genes, and genetic heterogeneity in clinical isolates of Acinetobacter spp. from Mangalore, India. Microbiol. Immunol. 55: 239-246
49. Kim, C.K., Y. Lee, H. Lee, G.J. Woo, W. Song, M.N. Kim, W.G. Lee, S.H. Jeong, K. Lee, and Y. Chong. (2010). Prevalence, and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182. Diagn. Microbiol. Infect. Dis. 68: 432-438
50. Kim, D.H., J.Y. Choi, H.W. Kim, S.H. Kim, D.R. Chung, K.R. Peck, V. Thamlikitkul, T.M. So, R.M. Yasin, P.R. Hsueh, et al. (2013). Spread of carbapenemresistant Acinetobacter baumannii global clone 2 in Asia, and AbaR-Type resistance islands. Antimicrob. Agents Chemother. 57: 5239-5246
51. Koh, T.H., L.H. Sng, G.C. Wang, L.Y. Hsu, and Y. Zhao. (2007). IMP-4, and OXA beta-lactamases in Acinetobacter baumannii from Singapore. J. Antimicrob. Chemother. 59: 627-632
52. Koh, T.H., T.T. Tan, C.T. Khoo, S.Y. Ng, T.Y. Tan, L.Y. Hsu, E.E. Ooi, T.J. Van Der Reijden (2012). Acinetobacter calcoaceticus-Acinetobacter baumannii complex species in clinical specimens in Singapore. Epidemiol. Infect. 140: 535-538
53. Kouyama, Y., S. Harada, Y. Ishii, T. Saga, A. Yoshizumi, K. Tateda, and K. Yamaguchi. (2012). Molecular characterization of carbapenem-non-susceptible Acinetobacter spp. in Japan: predominance of multidrug-resistant Acinetobacter baumannii clonal complex 92, and IMPtype metallo-beta-lactamase-producing non-baumannii Acinetobacter species. J. Infect. Chemother. 18: 522-528
54. Kuo, S.C., S.P. Yang, Y.T. Lee, H.C. Chuang, C.P. Chen, C.L. Chang, T.L. Chen, P.L. Lu, P.R. Hsueh, and C.P. Fung. (2013). Dissemination of imipenem-resistant Acinetobacter baumannii with new plasmid-borne blaOXA-72 in Taiwan. BMC Infect. Dis. 13: 319
55. La Scola, B., V.A. Gundi, A. Khamis, and D. Raoult. (2006). Sequencing of the rpoB gene, and flanking spacers for molecular identification of Acinetobacter species. J. Clin. Microbiol. 44: 827-832
56. Leclercq, R., R. Canton, D.F. Brown, C.G. Giske, P. Heisig, A.P. MacGowan, J.W. Mouton, P. Nordmann, A.C. Rodloff, G.M. Rossolini, et al. (2013). EUCAST expert rules in antimicrobial susceptibility testing. Clin. Microbiol. Infect. 19: 141-160
57. Lee, H.Y., R.C. Chang, L.H. Su, S.Y. Liu, S.R. Wu, C.H. Chuang, C.L. Chen, and C.H. Chiu. (2012). Wide spread of Tn2006 in an AbaR4-Type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan. Int. J. Antimicrob. Agents 40: 163-167
58. Lee, K., J.H. Yum, D. Yong, H.M. Lee, H.D. Kim, J.D. Docquier, G.M. Rossolini, and Y. Chong. (2005). Novel acquired metallo-beta-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates fromKorea. Antimicrob. Agents Chemother. 49: 4485-4491
59. Lee, M.F., C.F. Peng, H.J. Hsu, and Y.H. Chen. (2008). Molecular characterisation of the metallo-beta-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan. Int. J. Antimicrob. Agents 32: 475-480
60. Lee, Y., J. Lee, S.H. Jeong, J. Lee, I.K. Bae, and K. Lee. (2011). Carbapenem-non-susceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene. J. Antimicrob. Chemother. 66: 66-72
61. Lee, Y.T., C.P. Fung, F.D. Wang, C.P. Chen, T.L. Chen, and W.L. Cho. (2012). Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-Associated genetic structures in an intensive care unit. J. Microbiol. Immunol. Infect. 45: 43-51
62. Lee, Y.T., S.C. Kuo, M.C. Chiang, S.P. Yang, C.P. Chen, T.L. Chen, and C.P. Fung. (2012). Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a blaOXA-51-like gene that is intrinsic to A. baumannii. Antimicrob. Agents Chemother. 56: 1124-1127
63. Lin, W.R., P.L. Lu, L.K. Siu, T.C. Chen, C.Y. Lin, C.T. Hung, and Y.H. Chen. (2011). Rapid control of a hospitalwide outbreak caused by extensively drug-resistant OXA-72-producing Acinetobacter baumannii. Kaohsiung J. Med. Sci. 27: 207-214
64. Lin, Y.C., K.C. Hsia, Y.C. Chen, W.H. Sheng, S.C. Chang, M.H. Liao, and S.Y. Li. (2010). Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan. Antimicrob. Agents Chemother. 54: 2078-2084
65. Lu, P.L., M. Doumith, D.M. Livermore, T.P. Chen, and N. Woodford. (2009). Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase. J. Antimicrob. Chemother. 63: 641-647
66. Mendes, R.E., J.M. Bell, J.D. Turnidge, M. Castanheira, L.M. Deshpande, and R.N. Jones. (2009). Codetection of blaOXA-23-like gene (blaOXA-133), and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program. Antimicrob. Agents Chemother. 53: 843-844
67. Mostachio, A.K., A.S. Levin, C. Rizek, F. Rossi, J. Zerbini, and S.F. Costa. (2012). High prevalence of OXA-143, and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil. Int. J. Antimicrob. Agents 39: 396-401
68. Mugnier, P.D., L. Poirel, T. Naas, and P. Nordmann. (2010). Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 16: 35-40
69. Mussi, M.A., V.M. Relling, A.S. Limansky, and A.M. Viale. (2007). CarO, an Acinetobacter baumannii outer membrane protein involved in carbapenem resistance, is essential for L-ornithine uptake. FEBS Lett. 581: 5573-5578
70. Nakazawa, Y., R. Ii, T. Tamura, T. Hoshina, K. Tamura, S. Kawano, T. Kato, F. Sato, T. Horino, M. Yoshida, et al. (2013). A case of NDM-1-producing Acinetobacter baumannii transferred from India to Japan. J. Infect. Chemother. 19: 330-332
71. Nemec, A., L. Krizova, M. Maixnerova, T.J. van der Reijden, P. Deschaght, V. Passet, M. Vaneechoutte, S. Brisse, and L. Dijkshoorn. (2011). Genotypic, and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3), and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res. Microbiol. 162: 393-404
72. Nigro, S.J., V. Post, and R.M. Hall. (2011). Aminoglycoside resistance in multiply antibiotic-resistant Acinetobacter baumannii belonging to global clone 2 from Australian hospitals. J. Antimicrob. Chemother. 66: 1504-1509
73. Niranjan, D.K., N.P. Singh, V. Manchanda, S. Rai, and I.R. Kaur. (2013). Multiple carbapenem hydrolyzing genes in clinical isolates of Acinetobacter baumannii. Indian J. Med. Microbiol. 31: 237-241
74. Park, Y.K., S.I. Jung, K.H. Park, D.H. Kim, J.Y. Choi, S.H. Kim, and K.S. Ko. (2012). Changes in antimicrobial susceptibility, and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years. J. Med. Microbiol. 61: 71-79
75. Paton, R., R.S. Miles, J. Hood, S.G. Amyes, R.S. Miles, and S.G. Amyes. (1993). ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int. J. Antimicrob. Agents 2: 81-87
76. Peleg, A.Y., C. Franklin, L.J. Walters, J.M. Bell, and D.W. Spelman. (2006). OXA-58, and IMP-4 carbapenemhydrolyzing beta-lactamases in an Acinetobacter junii blood culture isolate from Australia. Antimicrob. Agents Chemother. 50: 399-400
77. Peleg, A.Y., H. Seifert, and D.L. Paterson. (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21: 538-582
78. Perichon, B., S. Goussard, V. Walewski, L. Krizova, G. Cerqueira, C. Murphy, M. Feldgarden, J. Wortman, D. Clermont, A. Nemec, et al. (2014). Identification of 50 class D beta-lactamases, and 65 Acinetobacter-derived cephalosporinases in Acinetobacter spp. Antimicrob. Agents Chemother. 58: 936-949
79. Poirel, L., R.A. Bonnin, A. Boulanger, J. Schrenzel, M. Kaase, and P. Nordmann. (2012). Tn125-related acquisition of blaNDM-like genes in Acinetobacter baumannii. Antimicrob. Agents Chemother. 56: 1087-1089
80. Poirel, L., S. Figueiredo, V. Cattoir, A. Carattoli, and P. Nordmann. (2008). Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob. Agents Chemother. 52: 1252-1256
81. Poirel, L., and P. Nordmann. (2006). Carbapenem resistance in Acinetobacter baumannii: mechanisms, and epidemiology. Clin. Microbiol. Infect. 12: 826-836
82. Poirel, L., and P. Nordmann. (2006). Genetic structures at the origin of acquisition, and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 50: 1442-1448
83. Runnegar, N., H. Sidjabat, H.M. Goh, G.R. Nimmo, M.A. Schembri, and D.L. Paterson. (2010). Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J. Clin. Microbiol. 48: 4051-4056
84. Saeed, S., M.G. Fakih, K. Riederer, A.R. Shah, and R. Khatib. (2006). Interinstitutional, and intrainstitutional transmission of a strain of Acinetobacter baumannii detected by molecular analysis: comparison of pulsed-field gel electrophoresis, and repetitive sequence-based polymerase chain reaction. Infect. Control Hosp. Epidemiol. 27: 981-983
85. Seifert, H., L. Dolzani, R. Bressan, T. van der Reijden, B. van Strijen, D. Stefanik, H. Heersma, and L. Dijkshoorn. (2005). Standardization, and interlaboratory reproducibility assessment of pulsed-field gel electrophoresisgenerated fingerprints of Acinetobacter baumannii. J. Clin. Microbiol. 43: 4328-4335
86. Sinha, N., J. Agarwal, S. Srivastava, and M. Singh. (2013). Analysis of carbapenem-resistant Acinetobacter from a tertiary care setting in North India. Indian J. Med. Microbiol. 31: 60-63
87. Snitkin, E.S., A.M. Zelazny, C.I. Montero, F. Stock, L. Mijares, P.R. Murray, and J.A. Segre. (2011). Genomewide recombination drives diversification of epidemic strains of Acinetobacter baumannii. Proc. Natl. Acad. Sci. U. S. A. 108: 13758-13763
88. Song, J.Y., H.J. Cheong, W.S. Choi, J.Y. Heo, J.Y. Noh, and W.J. Kim. (2011). Clinical, and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections. J. Med. Microbiol. 60: 605-611
89. Sung, J.Y., S.H. Koo, H.H. Cho, and K.C. Kwon. (2013). Nosocomial infection by sequence type 357 multidrugresistant Acinetobacter baumannii isolates in a neonatal intensive care unit in Daejeon, Korea. Ann. Lab. Med. 33: 279-282
90. Tada, T., T. Miyoshi-Akiyama, Y. Kato, N. Ohmagari, N. Takeshita, N.V. Hung, D.M. Phuong, T.A. Thu, N.G. Binh, N.Q. Anh, et al. (2013). Emergence of 16S rRNA methylase-producing Acinetobacter baumannii, and Pseudomonas aeruginosa isolates in hospitals in Vietnam. BMC Infect. Dis. 13: 251
91. Thapa, B., C. Tribuddharat, S. Srifuengfung, and C. Dhiraputra. (2010). High prevalence of blaOXA-23 in oligoclonal carbapenem-resistant Acinetobacter baumannii from Siriraj Hospital, Mahidol University, Bangkok, Thailand. Southeast Asian J. Trop. Med. Public. Health. 41: 625-635
92. Tian, G.B., J.M. Adams-Haduch, T. Bogdanovich, A.W. Pasculle, J.P. Quinn, H.N. Wang, and Y. Doi. (2011). Identification of diverse OXA-40 group carbapenemases, including a novel variant, OXA-160, from Acinetobacter baumannii in Pennsylvania. Antimicrob. Agents Chemother. 55: 429-432
93. Toleman, M.A., J. Spencer, L. Jones, and T.R. Walsh. (2012). blaNDM-1 is a chimera likely constructed in Acinetobacter baumannii. Antimicrob. Agents Chemother. 56: 2773-2776
94. Towner, K.J., K. Levi, and M. Vlassiadi. (2008). Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe. Clin. Microbiol. Infect. 14: 161-167
95. Turton, J.F., S.N. Gabriel, C. Valderrey, M.E. Kaufmann, and T.L. Pitt. (2007). Use of sequence-based typing, and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin. Microbiol. Infect. 13: 807-815
96. Turton, J.F., J. Matos, M.E. Kaufmann, and T.L. Pitt. (2009). Variable number tandem repeat loci providing discrimination within widespread genotypes of Acinetobacter baumannii. Eur. J. Clin.Microbiol. Infect. Dis. 28: 499-507
97. Turton, J.F., M.E. Ward, N. Woodford, M.E. Kaufmann, R. Pike, D.M. Livermore, and T.L. Pitt. (2006). The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258: 72-77
98. van Dessel, H., L. Dijkshoorn, T. van der Reijden, N. Bakker, A. Paauw, P. van den Broek, J. Verhoef, and S. Brisse. (2004). Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res. Microbiol. 155: 105-112
99. Vaneechoutte, M., L. Dijkshoorn, I. Tjernberg, A. Elaichouni, P. de Vos, G. Claeys, and G. Verschraegen. (1995). Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J. Clin. Microbiol. 33: 11-15
100. Vila, J., S. Marti, and J. Sanchez-Cespedes. (2007). Porins, efflux pumps, and multidrug resistance in Acinetobacter baumannii. J. Antimicrob. Chemother. 59: 1210-1215
101. Wailan, A.M., and D.L. Paterson. (2014). The spread, and acquisition of NDM-1: a multifactorial problem. Exp. Rev. Antiinfect. Ther. 12: 91-115
102. Walther-Rasmussen, J., and N. Hoiby. (2006). OXA-Type carbapenemases. J. Antimicrob. Chemother. 57: 373-383
103. Wang, H., P. Guo, H. Sun, H. Wang, Q. Yang, M. Chen, Y. Xu, and Y. Zhu. (2007). Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob. Agents Chemother. 51: 4022-4028
104. Wang, X., T. Chen, R. Yu, X. Lu, and Z. Zong. (2013). Acinetobacter pittii, and Acinetobacter nosocomialis among clinical isolates of the Acinetobacter calcoaceticus-baumannii complex in Sichuan, China. Diagn. Microbiol. Infect. Dis. 76: 392-395
105. Wang, Y., C. Wu, Q. Zhang, J. Qi, H. Liu, Y. Wang, T. He, L. Ma, J. Lai, Z. Shen, et al. (2012). Identification of New Delhi metallo-beta-lactamase 1 in Acinetobacter lwoffii of food animal origin. PLoS One 7: e37152
106. Wisplinghoff, H., C. Hippler, S.G. Bartual, C. Haefs, D. Stefanik, P.G. Higgins, and H. Seifert. (2008). Molecular epidemiology of clinical Acinetobacter baumannii, and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme. Clin. Microbiol. Infect. 14: 708-715
107. Yamamoto, M., M. Nagao, Y. Matsumura, G. Hotta, A. Matsushima, Y. Ito, S. Takakura, and S. Ichiyama. (2013). Regional dissemination of Acinetobacter species harbouring metallo-beta-lactamase genes in Japan. Clin. Microbiol. Infect. 19: 729-736
108. Yamamoto, M., M. Nagao, Y. Matsumura, A. Matsushima, Y. Ito, S. Takakura, and S. Ichiyama. (2011). Interspecies dissemination of a novel class 1 integron carrying blaIMP-19 among Acinetobacter species in Japan. J. Antimicrob. Chemother. 66: 2480-2483
109. Yang, J., Y. Chen, X. Jia, Y. Luo, Q. Song, W. Zhao, Y. Wang, H. Liu, D. Zheng, Y. Xia, et al. (2012). Dissemination, and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China. Clin. Microbiol. Infect. 18: E506-E513.
110. Yong, D., M.A. Toleman, C.G. Giske, H.S. Cho, K. Sundman, K. Lee, and T.R. Walsh. (2009). Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53: 5046-5054
111. Zander, E., R.A. Bonnin, H. Seifert, and P.G. Higgins. (2014). Characterization of blaOXA-143 variants in Acinetobacter baumannii, and Acinetobacter pittii. Antimicrob. Agents Chemother. 58: 2704-2708
112. Zander, E., A. Nemec, H. Seifert, and P.G. Higgins. (2012). Association between beta-lactamase-encoding blaOXA-51 variants, and DiversiLab rep-PCR-based typing of Acinetobacter baumannii isolates. J. Clin. Microbiol. 50: 1900-1904
113. Zarrilli, R., S. Pournaras, M. Giannouli, and A. Tsakris. (2013). Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int. J. Antimicrob. Agents 41: 11-19
114. Zhang, J.P., W. Zhu, S.F. Tian, Y.Z. Chu, and B.Y. Chen. (2010). Molecular characteristics, and resistant mechanisms of imipenem-resistant Acinetobacter baumannii isolates in Shenyang, China. J. Microbiol. (Seoul, Korea) 48: 689-694
115. Zhou, H., T. Zhang, D. Yu, B. Pi, Q. Yang, J. Zhou, S. Hu, and Y. Yu. (2011). Genomic analysis of the multidrugresistant Acinetobacter baumannii strain MDR-ZJ06 widely spread in China. Antimicrob. Agents Chemother. 55: 4506-4512
116. Zhou, Z., R. Guan, Y. Yang, L. Chen, J. Fu, Q. Deng, Y. Xie, Y. Huang, J. Wang, D. Wang, et al. (2012). Identification of New Delhi metallo-beta-lactamase gene (NDM-1) from a clinical isolate of Acinetobacter junii in China. Can. J. Microbiol. 58: 112-115
117. Zong, Z., and X. Zhang. (2013). blaNDM-1-carrying Acinetobacter johnsonii detected in hospital sewage. J. Antimicrob. Chemother. 68: 1007-1010